Neuroprotection of α-synuclein under acute and chronic rotenone and maneb treatment is abolished by its familial Parkinson's disease mutations A30P, A53T and E46K

Chi-Jing ChoongYee-How Say2024-11-042024-11-042011-12http://dx.doi.org/10.1016/j.neuro.2011.05.012https://dspace-cris.utar.edu.my/handle/123456789/6220Neuroprotection of α-synuclein under acute and chronic rotenone and maneb treatment is abolished by its familial Parkinson's disease mutations A30P, A53T and E46Kjournal-article